Abhimanyu  Verma net worth and biography

Abhimanyu Verma Biography and Net Worth

EVP, Chief Technology Officer of SOPHiA GENETICS
Abhimanyu (Abhi) Verma, M.Sc., M.B.A., is a healthcare technology leader experienced in developing capabilities and leading multifunctional organizations to create and accelerate solutions that impact patients and joined SOPHiA GENETICS in February 2022. He has more than 17 years of life sciences industry experience centered on harnessing the intersection of people, science, technology, data & AI serving multiple therapeutic areas and functions across the pharma value chain.
 
His leadership experience spans creating technology & information strategies; operating models; building teams and products; running operational platforms; and driving organizational and cultural transformation, with a relentless focus on outcomes and execution. Previously at Novartis, Abhi has proven to be a thought leader and execution champion at innovating and scaling data science and technology products, methodologies and approaches.
 
Passionate about cycling, comics, science fiction, and history, Abhi holds an M.B.A. from the Indian School of Business, a Master of Science in pharmaceutical medicine and is an engineer. He is also co-founder of the nonprofit Health Hacking Lab.

What is Abhimanyu Verma's net worth?

The estimated net worth of Abhimanyu Verma is at least $1.09 million as of April 6th, 2026. Mr. Verma owns 205,430 shares of SOPHiA GENETICS stock worth more than $1,094,942 as of May 1st. This net worth estimate does not reflect any other investments that Mr. Verma may own. Learn More about Abhimanyu Verma's net worth.

How do I contact Abhimanyu Verma?

The corporate mailing address for Mr. Verma and other SOPHiA GENETICS executives is , , . SOPHiA GENETICS can also be reached via phone at 41-21-694-1060. Learn More on Abhimanyu Verma's contact information.

Has Abhimanyu Verma been buying or selling shares of SOPHiA GENETICS?

Within the last three months, Abhimanyu Verma has sold $17,258.44 in SOPHiA GENETICS stock. Most recently, Abhimanyu Verma sold 1,030 shares of the business's stock in a transaction on Tuesday, April 7th. The shares were sold at an average price of $4.87, for a transaction totalling $5,016.10. Following the completion of the sale, the chief technology officer now directly owns 204,400 shares of the company's stock, valued at $995,428. Learn More on Abhimanyu Verma's trading history.

Who are SOPHiA GENETICS's active insiders?

SOPHiA GENETICS's insider roster includes Philippe Menu (Insider), Kevin Puylaert (SVP, Chief Sales Officer), and Abhimanyu Verma (EVP, Chief Technology Officer). Learn More on SOPHiA GENETICS's active insiders.

Are insiders buying or selling shares of SOPHiA GENETICS?

In the last twelve months, insiders at the sold shares 57 times. They sold a total of 193,859 shares worth more than $943,777.03. The most recent insider tranaction occured on April, 27th when insider Philippe Menu sold 5,000 shares worth more than $24,100.00. Insiders at SOPHiA GENETICS own 4.9% of the company. Learn More about insider trades at SOPHiA GENETICS.

Information on this page was last updated on 4/27/2026.

Abhimanyu Verma Insider Trading History at SOPHiA GENETICS

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/7/2026Sell1,030$4.87$5,016.10204,400View SEC Filing Icon  
4/6/2026Sell2,519$4.86$12,242.34205,430View SEC Filing Icon  
See Full Table

Abhimanyu Verma Buying and Selling Activity at SOPHiA GENETICS

This chart shows Abhimanyu Verma's buying and selling at SOPHiA GENETICS by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

SOPHiA GENETICS Company Overview

SOPHiA GENETICS logo
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.
Read More

Today's Range

Now: $5.32
Low: $5.23
High: $5.37

50 Day Range

MA: $4.81
Low: $4.10
High: $5.28

2 Week Range

Now: $5.32
Low: $2.59
High: $5.70

Volume

51,479 shs

Average Volume

169,220 shs

Market Capitalization

$364.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04